Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 19.53M | 36.48M | 37.96M | 615.94M | 1.23B |
Gross Profit | 9.90M | 11.64M | 18.47M | 125.21M | 221.48M |
EBITDA | -22.48M | -281.46M | -320.91M | -116.39M | 186.57M |
Net Income | -58.44M | -287.15M | -217.84M | -152.50M | 34.59M |
Balance Sheet | |||||
Total Assets | 689.43M | 713.28M | 1.08B | 1.34B | 1.23B |
Cash, Cash Equivalents and Short-Term Investments | 12.99M | 10.22M | 16.86M | 36.20M | 55.87M |
Total Debt | 584.84M | 607.51M | 655.65M | 629.76M | 555.25M |
Total Liabilities | 1.10B | 1.05B | 1.06B | 970.43M | 689.31M |
Stockholders Equity | -175.48M | -132.57M | 194.87M | 379.34M | 483.91M |
Cash Flow | |||||
Free Cash Flow | 4.05M | -4.95M | -17.99M | 15.00M | -491.32M |
Operating Cash Flow | 4.05M | -4.51M | -17.70M | 15.62M | -490.81M |
Investing Cash Flow | 1.69M | -359.00K | 4.70M | 2.67M | -103.00K |
Financing Cash Flow | -1.38M | -1.93M | -7.48M | -41.83M | 490.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | HK$457.69M | 5.47 | 57.03% | 8.25% | 48.34% | 40.71% | |
55 Neutral | HK$68.54B | -1.86 | -3.62% | 5.63% | -4.09% | -17.08% | |
51 Neutral | HK$71.83M | ― | -58.38% | ― | -14.40% | 25.64% | |
47 Neutral | HK$18.93M | 2.35 | 105.83% | ― | 5.73% | 75.18% | |
41 Neutral | HK$74.15M | ― | -34.21% | ― | -1.68% | 49.77% | |
27 Underperform | HK$36.41M | ― | ― | -41.38% | 77.84% | ||
21 Underperform | HK$22.65M | ― | ― | 16.32% | 57.06% |